Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|4|404-409

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.4, 2015-04, pp. : 404-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment on: Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 8, 2015-12 ,pp. : 907-908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20‐year survey by the Italian Liver Cancer group

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 223-231

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 5, 2015-05 ,pp. : 514-522

John Wiley & Sons Inc

Access to resources Recommend Favorite